ASM has announced the launch of mBio™, the Society’s first broad-scope, open-access online journal (which means it can be accessed for free). Readers can get an inside glimpse of the latest via mBiosphere, the journal’s blog run by Merry Buckley. (What were the chances of two Merrys writing blogs for the ASM?) Arturo Casadevall, the Founding Editor-in-Chief, says the new journal is a good choice for scientists who wish to publish cutting-edge research quickly.
mBio is published in association with the American Academy of Microbiology, the honorific leadership group within the ASM. The Academy’s mission is to recognize scientists for outstanding contributions to microbiology, which is in synch with mBio’s mission to publish high-quality articles across the entire field of microbiology. Here’s a sample of work that will be reported in the inaugural issue of mBio that will be online in mid-May:
- a way to produce a disease state in infant rabbits much like human cholera.
- progress toward the goal of an influenza virus vaccine that would protect against multiple strains
- identification of numerous targets across the entire E. coli chromosome to which SeqA binds
- the first evidence for a biofilm cell protein that senses the presence of completion of synthesis extracellular matrix
- demonstration of the existence of ~1,000 antisense RNAs in E. coli, which may represent an important but overlooked class of regulatory molecule
- two major new papers on Cryptococcus neoformans, an AIDS-associated human fungal pathogen
- an intriguing essay proposing that global preparedness for the effects of climate change should consider the possibility of an increased prevalence of fungal diseases in mammals
We wish this new journal much success.